Onvatilimab | m-entrepreneurship.com

Product Name :
Onvatilimab

Search keywords :
Onvatilimab

drugId :
null

Target Vo:
V-domain Ig suppressor of T-cell activation

Target Vo Short Name :
VISTA

Moa_Name:
V-domain Ig suppressor of T-cell activation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunext Inc

Active Company_Name :
Curis Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ChAT Antibody Protocol
Anti-Mouse CD86/B7-2 Antibody (GL-1) Autophagy
Phospho-Cyclin B1 (Ser126) Antibody: Phospho-Cyclin B1 (Ser126) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to Phospho-Cyclin B1 (Ser126). It can be used for WB,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts